Maxiflo 125 Inhaler

What Is Maxiflo 125 Inhaler?

Maxiflo 125 Inhaler is an inhalation medicine formulated with two active components:

• Budesonide, a corticosteroid that decreases inflammation in the airways

• Formoterol fumarate dihydrate, a long-acting beta-2 agonist (LABA) that relaxes bronchial smooth muscle

This inhaler is indicated for the long-term control and prevention of asthma symptoms and may also be used in select cases of COPD management when prescribed by a clinician. It works by improving airflow and reducing chronic airway irritation, helping patients maintain better respiratory function and reduce episodes of wheezing, breathlessness, and chest tightness.

How Maxiflo 125 Inhaler Works

This combination inhaler works through dual mechanisms:

1. Anti-inflammatory Action (Budesonide):
   Helps suppress chronic inflammation in the airway linings.

2. Sustained Bronchodilation (Formoterol):
   Relaxes bronchial muscles, improving airflow and reducing symptoms.

This dual effect supports long-term asthma control and helps maintain stable breathing patterns over time when used consistently as directed.

Indications

Maxiflo 125 Inhaler is generally prescribed for:

• Maintenance treatment of asthma

• COPD maintenance (when clinically appropriate)

• Prevention of asthma symptoms and exacerbations

Use should always be determined by a healthcare provider based on the patient’s respiratory condition.

Usage & Administration

• Use exactly as prescribed by your healthcare provider

• Typically administered twice daily

• Rinse mouth after inhalation to reduce irritation or oral yeast risk

• Not intended for immediate relief of sudden breathing difficulty — a rescue inhaler should be used instead

Always follow clinical guidance for dosage and frequency.

Dry-powder inhalation therapy options can be supported through structured respiratory delivery systems such as Asthalin Rotacap for effective airway control.

Safety Information & Precautions

Before using Maxiflo 125 Inhaler, tell your clinician if you have:

• Heart or cardiovascular conditions

• High blood pressure

• Thyroid disorders

• Diabetes

• Frequent infections or immune system issues

Long-term inhaled corticosteroid therapy protocols align with maintenance control strategies supported by Ciclohale 160 Mcg Inhaler.

Important Safety Notes:

• This inhaler is for maintenance therapy, not acute relief

• Do not stop treatment abruptly without clinician approval

• Regular follow-up may be required

Possible Side Effects

Side effects may occur, though many are mild:

• Throat irritation

• Hoarseness

• Cough

• Headache

• Tremor

• Oral yeast infections (uncommon)

If side effects are severe or persistent, consult your healthcare provider.

Drug Interactions

Inform your clinician about all medications and supplements, especially:

• Other corticosteroids

• Long-acting or short-acting bronchodilators

• Beta-blockers

• Antidepressants

• Antifungal medications

Interactions may influence therapeutic effects or increase side-effect risks.

Authoritative pharmacological reference standards and bronchodilator therapy information are supported by MedlinePlus – Salbutamol Drug Info.

Use in Special Populations

Pregnancy & Breastfeeding:
Consult your clinician before use.

Pediatric:
Use should be guided by a qualified healthcare provider.

Elderly:
Age-related considerations may require monitoring.

Monitoring & Follow-Up

Your healthcare provider may assess:

• Symptom frequency and severity

• Lung function (peak flow or spirometry)

• Side effects

• Inhaler technique

Storage Instructions

• • Store at room temperature (below 25 °C)

  • Keep away from direct sunlight and moisture

  • Keep out of reach of children

  • Do not use after expiry

    FAQs